Results 191 to 200 of about 13,220 (219)

Use of Ceftazidime-Avibactam and Ceftolozane-Tazobactam After Lung Transplantation

Transplantation Proceedings, 2020
After lung transplantation (LTx), infections caused by multidrug-resistant (MDR) bacteria are frequent and difficult to treat. Some new antibiotics seem to be effective in treating these infections.We describe our experience in treatment of Klebsiella pneumoniae MDR and Pseudomonas aeruginosa MDR infections with ceftazidime-avibactam (CEF-AVI) and ...
Amore D., Pecoraro Y., Carillo C., Russo G., Poggi C., Anile M., Pagini A., Bassi M., Cagnetti S., Mottola E., D'Agostino F. G., Vannucci J., Mantovani S., Pugliese F., De Giacomo T., Rendina E. A., Venuta F., Diso D.   +17 more
openaire   +2 more sources

Therapeutic insights: Use of ceftazidime‐avibactam in pediatric patients

Pediatrics International
Abstract Background The increasing worldwide prevalence of multidrug‐resistant (MDR) bacteria underscores the pressing demand for innovative therapeutic solutions. Ceftazidime‐avibactam (CAZ‐AVI) represents a promising new drug combination that has received approval for specific infection types.
Özge Metin Akcan, Mustafa Gençeli, Talha Üstüntaş, Abdullah Akkuş, Sevgi Pekcan, Metin Doğan   +5 more
openaire   +2 more sources

Ceftazidime-avibactam use in hematology patients: single-center experience

European Journal of Clinical Microbiology & Infectious Diseases
To investigate the efficacy of the cephalosporin/ beta lactamase inhibitor combination ceftazidime-avibactam in hematology patients with hematopoietic stem cell transplantation or receiving chemotherapy alone.In this study, 80 patients who were followed up in the Stem Cell Transplant Center and Hematology Clinic of Istinye University Gaziosmanpaşa ...
Aysun, Halacoglu, Mustafa, Koroglu, Mehmet, Ozen   +2 more
openaire   +2 more sources

Safety evaluation of ceftazidime/avibactam based on FAERS database

Infection
To explore adverse event (AE) signals of Ceftazidime/avibactam (CZA) based on the FDA Adverse Event Reporting System (FAERS) database.AE reports primarily associated with CZA were retrieved from the FAERS database from the second quarter of 2015 to the second quarter of 2023.
Xiuhong, Zhang, Ying, Jiang, Yating, Guo, Wenbo, Zhou, Weizhen, Qiao, Haohao, Zhu, Zhigang, Qi   +6 more
openaire   +2 more sources

Studying ceftazidime-avibactam in selected populations

The Lancet Infectious Diseases, 2016
Florian M E, Wagenlehner, Kurt G, Naber
openaire   +2 more sources

Ceftazidime–Avibactam Sodium

2021
openaire   +1 more source

Klebsiella pneumoniae Carbapenemase Variants Resistant to Ceftazidime-Avibactam: an Evolutionary Overview

Antimicrobial Agents and Chemotherapy, 2022
Olivier Tenaillon, Beatrice Bercot, Herve Jacquier   +2 more
exaly  

Ceftazidime/Avibactam Sodium

2020
openaire   +1 more source

Review of Ceftazidime-Avibactam for the Treatment of Infections Caused by Pseudomonas aeruginosa

Antibiotics, 2021
George L Daikos, Gian Maria Rossolini, Gregory G Stone   +2 more
exaly  

Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia

Antimicrobial Agents and Chemotherapy, 2017
Ryan K Shields, Liang Chen, Yohei Doi
exaly